Detalhe da pesquisa
1.
Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel.
Blood
; 143(19): 1891-1902, 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38295337
2.
Management of ALL in adults: 2024 ELN recommendations from a European expert panel.
Blood
; 143(19): 1903-1930, 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38306595
3.
Single agent subcutaneous blinatumomab for advanced acute lymphoblastic leukemia.
Am J Hematol
; 99(4): 586-595, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38317420
4.
Proton pump inhibition for secondary hemochromatosis in hereditary anemia: a phase III placebo-controlled randomized cross-over clinical trial.
Am J Hematol
; 97(7): 924-932, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35472008
5.
Luspatercept as Potential Treatment for Congenital Sideroblastic Anemia.
N Engl J Med
; 388(15): 1435-1436, 2023 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37043658
6.
Adolescents and Young Adults Living With an Uncertain or Poor Cancer Prognosis: The "New" Lost Tribe.
J Natl Compr Canc Netw
; 19(3): 240-246, 2021 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33668023
7.
Identification of genetic biomarkers for alloimmunization in sickle cell disease.
Br J Haematol
; 186(6): 887-899, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31168801
8.
Nonclassical FCGR2C haplotype is associated with protection from red blood cell alloimmunization in sickle cell disease.
Blood
; 130(19): 2121-2130, 2017 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28899854
9.
Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in sickle cell disease: A phase 2, open-label study.
Am J Hematol
; 97(7): E226-E229, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35384026
10.
Early occurrence of red blood cell alloimmunization in patients with sickle cell disease.
Am J Hematol
; 91(8): 763-9, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27102719
11.
Iron refractory iron deficiency anemia: a heterogeneous disease that is not always iron refractory.
Am J Hematol
; 91(12): E482-E490, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27643674
12.
Incentive spirometry to prevent acute chest syndrome in adults with sickle cell disease; a randomized controlled trial.
Am J Hematol
; 95(7): E160-E163, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32242978
13.
Tyrosine kinase inhibitor resistance in de novo BCR::ABL1-positive BCP-ALL beyond kinase domain mutations.
Blood Adv
; 8(8): 1835-1845, 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38386975
14.
Oxygen gradient ektacytometry-derived biomarkers are associated with acute complications in sickle cell disease.
Blood Adv
; 8(2): 276-286, 2024 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37976458
15.
Benefits and risks of clofarabine in adult acute lymphoblastic leukemia investigated in depth by multi-state modeling.
Cancer Med
; 13(9): e6756, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38680089
16.
No significant prognostic value of normal precursor B-cell regeneration in paediatric acute myeloid leukaemia after induction treatment.
Br J Haematol
; 161(6): 861-4, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23577982
17.
Effect of N-acetylcysteine on pain in daily life in patients with sickle cell disease: a randomised clinical trial.
Br J Haematol
; 182(3): 444-448, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28643376
18.
Allogeneic Stem Cell Transplantation in Patients >40 Years of Age With Acute Lymphoblastic Leukemia: Reduced Intensity Versus Myeloablative Conditioning.
Transplantation
; 107(12): 2561-2567, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37389645
19.
One-year safety and efficacy of mitapivat in sickle cell disease: follow-up results of a phase 2, open-label study.
Blood Adv
; 7(24): 7539-7550, 2023 12 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37934880
20.
Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic value.
Blood
; 116(12): 2122-6, 2010 Sep 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-20538800